- Registration projects in health and health care
Registration projects in health and health care
Oncofreezing is a project which involves a reimbursement by the mandatory health insurance concerning the collection, freezing and conserving of gametes or gonadal tissue prior to an anticancer treatment or prior to a preventive oophorectomy. This is done in order to safeguard the possibility of procreation of the patients who might want to make use of medically assisted procreation or the re-implantation of gonadal tissue in a later life phase.
For the support of Oncofreezing, a convention is agreed upon between RIZIV-INAMI and the care centres.
Molecular detection is currently a part of clinical oncology diagnostics. The recent grow of advanced molecular technologies enables for a certain number of cases to optimize the treatment by incorporating individual, molecular DNA-characteristics of the tumor and of the patient himself: the so-called ‘Targeted Next-Generation-Sequencing (NGS).
The introduction of NGS in molecular oncology diagnostics requires a profound preparatory phase, both in the field and on policy level. A feasibility study, performed by the Cancer center (WIV-ISP) and the KCE, resulted in a roadbook ‘...
Order sets could serve as a form of decision support for laboratory testing. They could assist the physicians and their patient in making an informed decision on which tests to order for a given indication. Literature suggests that one in three ordered laboratory tests are inappropriate. Inadequate testing may influence quality of care negatively. Further research therefore is needed regarding the potential effects if order sets would be implemented in GP practice.
Also, there is evidence in literature suggesting that the use of order sets may reduce the amount of ordered lab tests...
For a number of diseases/disorders, personalized treatment today offers a great added value compared to classical, empirical therapy. Thanks to molecular diagnostics, specific aberrations can be detected, which are an indication for a correct diagnosis and prognosis and the successful use of a corresponding drug in order to target the disease.
Currently the reimbursement of personalized medicines is not coupled with that of the accompanying biomarker which often leads to a delay in reimbursement of the predictive tests as compared to the personalized medicine. To better align...